Related by context. Frequent words. (Click for all words.) 67 Act PDUFA date 64 alvimopan 63 Phenoptin 63 Complete Response 63 Pivotal Phase III 63 supplemental Biologics License Application 62 Pivotal Phase 62 SILENOR TM 62 Marketing Authorization Application MAA 61 Marketing Authorization Application 61 alogliptin 61 QNEXA 61 Icatibant 61 VIMOVO 60 Biologics License Application BLA 60 Approvable Letter 60 Biologics License Application 60 pseudobulbar affect PBA 60 Investigational Device Exemption 60 PDUFA date 60 Phase III Clinical Trial 59 Complete Response letter 59 Drug Application 59 PROMACTA 59 Pirfenidone 59 Orphan Drug Status 59 Omigard 59 Symbyax 59 bazedoxifene 58 NEBIDO 58 injectable formulation 58 Trexima 58 fingolimod 58 sNDA 58 Board DSMB 58 6R BH4 58 sBLA 58 BLA submission 58 Cethromycin 58 Act PDUFA 58 Entereg 58 ONTAK 58 Torisel 58 PRISTIQ 58 ATryn ® 58 Zelrix 57 Fast Track designation 57 Marketing Authorization 57 Orphan Drug status 57 Pivotal Trial 57 Treximet 57 methylnaltrexone 57 cangrelor 57 FIRAZYR 57 REVLIMID R 57 Fast Track Designation 57 orphan medicinal product 57 ATryn R 57 Stedivaze 57 Amrubicin 57 ZALBIN 57 Neurodex 57 eltrombopag 57 RHUCIN 57 Completes Enrollment 57 Cladribine 57 REMICADE ® 57 Staccato loxapine 57 velaglucerase alfa 57 Genasense R oblimersen 57 Horizant 57 PREOS 57 zileuton 57 New Drug Application 57 Extended Release 57 Orphan Drug designation 56 maribavir 56 TORISEL 56 milnacipran 56 Jevtana 56 BioDelivery Sciences 56 Oral Solution 56 OFIRMEV 56 pediatric exclusivity 56 Drug Candidate 56 NOXAFIL 56 hypercalcemia 56 Rivaroxaban 56 NDA submission 56 squalamine 56 Exalgo 56 Riquent 56 Ofatumumab 56 Zerenex 56 confirmatory Phase III 56 elotuzumab 56 TYKERB 56 SinuNase 56 Extended Release Tablets 56 Priority Review 56 vernakalant iv